Skip Navigation
Skip to contents

대한내분비학회

전체메뉴

대한내분비학회 내분비질환 관련 임상 및 기초 연구자들의 학술 활동의 구심점 역할을 충실히 수행합니다.

내분비 회원 저널 소개

Home > 학회지&간행물 > 내분비 소식지
  • 글자를 크게
  • 글자를 작게
  • 현재 페이지 프린트하기
학회지&간행물
게시판 검색 ~
번호 카테고리 EnM 인용 제목 저자 저널명 출판년도/월
2522 당뇨병/비만/지질 Phenylbutyrate Ameliorates High-Fat Diet-Induced Obesity via Brown Adipose Tissue Activation. In Kyu Lee Biological & pharmaceutical bulletin 2019/NA
2521 당뇨병/비만/지질 Correction: Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight. Hye Seung Jung PloS one 2019/NA
2520 당뇨병/비만/지질 Influence of Microbiota on Diabetic Foot Wound in Comparison with Adjacent Normal Skin Based on the Clinical Features. Min Ji Jeon,Won Gu Kim,Tae Yong Kim,Won Bae Kim,Young Kee Shong BioMed research international 2019/NA
2519 당뇨병/비만/지질 Potential Diagnostic Hemorheological Indexes for Chronic Kidney Disease in Patients With Type 2 Diabetes. Lee Jun Ho Frontiers in physiology 2019/NA
2518 당뇨병/비만/지질 Carvedilol improves glucose tolerance and insulin sensitivity in treatment of adrenergic overdrive in high fat diet-induced obesity in mice. Kim Eui Hyun PloS one 2019/NA
2517 당뇨병/비만/지질 Gestational diabetes mellitus diagnosed at 24 to 28 weeks of gestation in older and obese Women: Is it too late? Kim Yoo Lee PloS one 2019/NA
2516 당뇨병/비만/지질 Age-specific diabetes risk by the number of metabolic syndrome components: a Korean nationwide cohort study. Hyuk Sang Kwon,Lee Min Kyung Diabetology & metabolic syndrome 2019/NA
2515 당뇨병/비만/지질 Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice. Joong Yeol Park,Chang Hee Jung Diabetes, metabolic syndrome and obesity : targets and therapy 2019/NA

상단으로 이동

Copyright ⓒ The Korean Endocrine Society. All rights Reserved

  • [04146] 서울특별시 마포구 마포대로 109 롯데캐슬프레지던트 101동 2503호
  • 사업자 등록번호 : 106-82-31113
  • 대표자 성명 : 홍은경
  • Tel : 02-714-2428 | Fax : 02-714-5103 | E-mail : endo@endocrinology.or.kr
SNS
instagram facebook twitter